Deep Dutta
Overview
Explore the profile of Deep Dutta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
1264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dutta D, Kumar M, Joshi A, Sharma M
Ann Afr Med
. 2025 Mar;
PMID: 40053429
Aims: Three percent hypertonic saline (3NS) is an established treatment for severe hyponatremia. The optimal regimen for administering 3NS for severe hyponatremia, with the aim to minimize side effects is...
2.
Kamrul-Hasan A, Pappachan J, Nagendra L, Ashraf H, Dutta D, Bhattacharya S, et al.
Clin Obes
. 2025 Mar;
:e70008.
PMID: 40049152
Data from clinical trials evaluating the effectiveness and safety of metabolic and bariatric surgery (MBS) compared to lifestyle modifications (LSM) in children and adolescents with obesity are scarce. This systematic...
3.
Kamrul-Hasan A, Patra S, Dutta D, Nagendra L, Muntahi-Reza A, Borozan S, et al.
World J Diabetes
. 2025 Feb;
16(2):101282.
PMID: 39959269
Background: Type 2 diabetes (T2D), as well as obesity, are risk factors for chronic kidney disease (CKD) and end-stage renal disease. The renal impacts of glucose-lowering and weight-lowering drugs and...
4.
Sharma M, Das S, Mohindra R, Dutta D
Int J Rheum Dis
. 2025 Feb;
28(2):e70106.
PMID: 39895497
Aims: No meta-analysis has holistically analyzed and summarized the efficacy and safety of tocilizumab in polymyalgia rheumatica (PMR). We undertook this meta-analysis to address this knowledge-gap. Methods: Electronic databases were...
5.
Kamrul-Hasan A, Alam M, Dutta D, Sasikanth T, Aalpona F, Nagendra L
Endocrinol Metab (Seoul)
. 2025 Jan;
40(1):112-124.
PMID: 39814031
Backgruound: Data on the carcinogenic potential of tirzepatide from randomized controlled trials (RCTs) are limited. Furthermore, no meta-analysis has included all relevant RCTs to assess the cancer risk associated with...
6.
Kamrul-Hasan A, Borozan S, Dutta D, Nagendra L, Shrestha D, Pappachan J
Endocr Pract
. 2024 Dec;
PMID: 39733942
No abstract available.
7.
Nagendra L, Chandran M, Reginster J, Bhadada S, Bhattacharya S, Dutta D, et al.
Osteoporos Int
. 2024 Dec;
36(2):311-322.
PMID: 39730734
Purpose: Osteoporosis represents a significant public health challenge in India, with an increasing economic burden due to the aging population. This study evaluated the cost-effectiveness of using fracture risk assessment...
8.
Kamrul-Hasan A, Mondal S, Dutta D, Nagendra L, Kabir M, Pappachan J
Obes Sci Pract
. 2024 Dec;
10(6):e70032.
PMID: 39720158
Background: Endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate islet cell function. GLP-1 receptor agonists (GLP-1RAs) have been associated with an elevated risk of acute pancreatitis. Data on...
9.
Dutta D, Nagendra L, Kumar M, Kamrul-Hasan A, Bhattacharya S
Endocr Pract
. 2024 Dec;
PMID: 39710291
Objective: No meta-analysis has holistically analyzed and summarized the efficacy and safety of the novel once-weekly basal insulin efsitora alfa in managing type 1 diabetes (T1D) and type 2 diabetes...
10.
Bhattacharya S, Nagendra L, Dutta D, Kamrul-Hasan A
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39689014
Purpose: Early gestational diabetes mellitus (eGDM) refers to elevated blood glucose levels not meeting the criteria for overt diabetes before 20 weeks gestation. Observational studies link eGDM to adverse outcomes,...